Mifepristone Court Hearing Will Tackle Accelerated Approval, Comstock

By Beth Wang / March 14, 2023 at 6:56 PM
Clarification Appended A Wednesday (March 15) court hearing to determine the future of access to the abortion pill, mifepristone, will tackle FDA’s accelerated approval regulations, pediatric study requirements for drugs and whether federal law allows mailing of medication abortion, the judge informed the attorneys in the case. The hearing is part of a high-profile suit that could reverse FDA’s more than 20-year-long approval of mifepristone -- one of two pills used as part of a medication abortion...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.